Loading clinical trials...
Loading clinical trials...
Efficacy and Safety Comparison of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Associated With Doxycycline Hyclate 100 mg Tablets Versus Adapalene 0.1% / Benzoyl Peroxide 2.5% Vehicle Gel Associated With Doxycycline Hyclate 100 mg Tablets in the Treatment of Severe Acne Vulgaris.
Conditions
Interventions
Adapalene BPO Gel associated with Doxycyline Hyclate
Vehicle Gel associated with Doxycycline Hyclate
Locations
34
United States
Galderma Investigational Site
Oceanside, California, United States
Galderma Investigational Site
San Diego, California, United States
Galderma Investigational Site
Denver, Colorado, United States
Galderma Investigational Site
Longmont, Colorado, United States
Galderma Investigational Site
Miami, Florida, United States
Galderma Investigational Site
Snellville, Georgia, United States
Start Date
August 1, 2008
Primary Completion Date
February 1, 2009
Completion Date
February 1, 2009
Last Updated
February 18, 2021
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions